KZA 1.59% 62.0¢ kazia therapeutics limited

nrt's box with jewels

  1. 22,691 Posts.
    This was my reply to someone's post on another channel:

    " Sure Mr X,

    I would put it this way: Time favours NRT.

    Regardless of the Conference, once it finishes on June 2, then it shouldn't be too long before we shall have that ISOFLAVONE Patent.

    As already mentioned in post 7670, it is a very valuable Patent and is rated at $2.50/share.

    From then on or before June 30, I see us going into the long talked about NV04 trials; CFlipP heavily favours NV04 and so do I.

    It is quite possible that its success and valuation will far outstrip that of Phenoxodiol. Hence the urgency to get that trial going. Prel. value/share $1.50 (before further trials start).

    In the meantime or following the start of the NV04 trial, the NV07a drug ought to get going. Prel. value of NV07a: $3.30 /per share on Commercialisation. Some of that will be in the current share price, reducing it to $3/share.

    The estimated value of NV07a when added to that of the Isoflavones should be considerable: about $5.50 for these 2 products alone.

    Further out still, we hope to get the Osteoporosis Patents, worth a tidy sum.

    As to trials, we have started the Skin Cancer and Skin Ulcer trials, the first was started because of a very good indication.

    What many Investors can't comprehend are the massive markets these products can control in nearly every case eg. if that drug NV04 is successful, then some share holders will be set for life. The market is so massive that quoting any numbers is a sheer waste of time.

    And so Mr X, I feel it worthwhile always to talk about something which is already there and does not need testing: Isoflavones, NV07a are just some examples.

    Having said that, sure the Ovarian trials are important but they started late and I would favour those without chemotherapy.

    But I realize, Yale had to tackle those cases first. I would think that these trials will be continued for some time yet.

    Gerry

    NOVOGEN: THERE IS ALWAYS MORE AND MORE....

 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist
(20min delay)
Last
62.0¢
Change
-0.010(1.59%)
Mkt cap ! $45.46M
Open High Low Value Volume
63.0¢ 63.0¢ 62.0¢ $28.61K 46.07K

Buyers (Bids)

No. Vol. Price($)
1 6000 60.5¢
 

Sellers (Offers)

Price($) Vol. No.
62.0¢ 4534 1
View Market Depth
Last trade - 12.29pm 23/01/2020 (20 minute delay) ?
(live)
Last
61.5¢
  Change
-0.010 ( 1.60 %)
Open High Low Volume
62.0¢ 62.0¢ 61.5¢ 6588
Last updated 12.29pm 23/01/2020 (live) ?
KZA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.